<< Back
NextGen Healthcare Releases Significant Product Enhancements to its EHR-agnostic Mobile Suite, Including Support for Inpatient Workflows and ICD-10 Coding
November 16, 2017 at 7:30 AM EST

IRVINE, Calif.--(BUSINESS WIRE)-- Quality Systems, Inc. (NASDAQ: QSII), known to its clients as NextGen Healthcare, today announced significant product enhancements to its mobile workflow solution, including new functionality that enables physicians to utilize speech-driven documentation support in both clinic and hospital settings and facilitates the management of ICD-10 diagnoses to accelerate billing. The new functionality drives time savings for caregivers by increasing workflow efficiency, improving access to patient information and streamlining common clinic and administrative tasks.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171116005714/en/

NextGen Healthcare's mobile suite helps providers across the continuum of care regain time so they c ...

NextGen Healthcare's mobile suite helps providers across the continuum of care regain time so they can focus on what matters most, delivering exceptional patient care. (Photo: Business Wire)

This platform upgrade is the first major product enhancement from Entrada following its acquisition by NextGen Healthcare, earlier this year.

Providers often work from multiple care settings - including outpatient clinics, surgery centers and hospitals - each with unique workflows and charting requirements. NextGen Mobile Suite now provides clinical documentation support specifically for the hospital setting, enabling providers to switch between inpatient and outpatient use cases from within a single mobile interface. With real-time access to the hospital census list, providers can use speech-driven documentation options (speech-to-text, transcription and remote scribe) to capture robust patient notes at the point-of-care during hospital rounds.

In addition to inpatient support, NextGen Mobile Suite now provides mobile access to the industry-leading IMO Problem IT Terminology diagnosis entry tool, powered by Intelligent Medical Objects, Inc. (IMO). The tool is embedded directly inside the platform, allowing users to expedite and simplify entering diagnosis codes into their EHRs. The tool, with more than 800,000 unique clinical concepts and 1.8+ million synonyms, ensures the accurate capture of physicians' narrative and integration with EHR terminology.

Other new product enhancements allow providers to:

  • Enable physicians to electronically sign documents from the mobile device.
  • Annotate on clinical images captured from Entrada prior to sending to the EHR.
  • Utilize fast and secure finger-print login on physicians' mobile devices.

"Industry dynamics are requiring physicians to be proficient in technology across multiple systems, devices and care settings. Our goal is simple - to provide easy-to-use solutions that allow clinicians to remain focused on delivering quality patient care and practice meaningful medicine," said Rusty Frantz, President and CEO of NextGen Healthcare. "With these new enhancements, our platform allows physicians, and their entire care team, to remain productive by reducing the administrative burden, ultimately enabling better workflow management across systems, both in the ambulatory and inpatient setting alike."


This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements made by Rusty Frantz, President and CEO, statements regarding enhancements to the Company's Entrada product, and other statements regarding future events, developments in the Company's business and in the overall healthcare sector, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future. The Company cautions investors not to place undue reliance on any such forward-looking statements, which are based on information available at the time those statements are made or management's good faith belief as of that time with regard to future events, and should not be read as a guarantee of future performance or results. Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements and additional risks and uncertainties are set forth in Part I, Item A of our most recent Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; disruptions caused by acquisitions of companies, products, or technologies; and general economic conditions. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

About Quality Systems, Inc.

Quality Systems, Inc., known to its clients as NextGen Healthcare, provides a range of software, services, and analytic solutions to medical and dental group practices. The Company's portfolio delivers foundational capabilities to empower physician success, enrich the patient care experience and enable the transition to value-based healthcare. Visit www.qsii.com and www.nextgen.com for additional information.

About Intelligent Medical Objects, Inc. (IMO)

Intelligent Medical Objects, Inc. (IMO), is the developer of the most widely-accepted medical terminology solution for the management of medical vocabularies and software applications at healthcare organizations worldwide. IMO's terminology is used by more than 3,500 hospitals and 450,000 physicians daily, and this trusted terminology platform supports innovations by provider systems. IMO medical vocabulary and mapping products effectively capture clinical intent and help EMRs preserve and communicate this across the entire spectrum of care. IMO clinical terms are mapped to all standard coding systems including ICD-9, ICD-10, and SNOMED®. The accuracy of IMO's interface terminology was found to be "nearly perfect" in an independent study published by the US Centers for Disease Control. Visit www.e-imo.com.

For Media and Public Relations Inquiries:
Finn Partners:
Agata Porter, (212) 715-1595

Source: NextGen Healthcare

News Provided by Acquire Media